1st EUFEPS Talk

 

We want to invite you to the first EUFEPS Talk on November 30, 2020.

Dr. Felipe Prosper will give a talk with the title: "Advanced therapy with Mesenchymal Stromal Cells for inflammatory diseases: is there a role for MSC in COVID-19".

 

Abstract

The use of Multipotent mesenchymal stromal cells (MSCs) have been extensively investigated as an
advanced therapy medicinal product, with promising results in inflammatory and degenerative diseases.
MSC from different sources have been investigated as treatment for graft-versus-host disease (GvHD),
multiple sclerosis (MS), Crohn’s disease (CD), amyotrophic lateral sclerosis (ALS), myocardial
infarction (MI), and acute respiratory distress syndrome (ARDS), among others. Their therapeutic effect
depends not only on cell-cell contact but also may include a so-called hit-and-run mechanism. However,
with more than 300 completed clinical trials using MSCs as of 2020 and despite a wealth of information
available to better understand what dictates their success and failure when investigated in humans
there is only one product with marketing authorization within the EU. I will review some of the bases for
the use of MSC in different diseases, providing results based on our experience and will discuss the
rational for the use of MSC in patients with severe COVID-19 pneumonia. Initial results from the first
experience with adipose derived MSC in Europe will also be described.

Registration:

A registration is needed for this event. Please use the following link:  https://zoom.us/meeting/register/tJYodeqvqTsvHNxNcILE9YN1Mu3sZEK04LUf. After the regristration you will receive an E-Mail with the log-in details.

 

Go back